ckd-825

Small moleculeexperimental

Clinical trial activity

1 trials · 19 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
0

Earliest trial started Apr 23, 2019 (NCT03950843)

Timeline

2010s

  1. Jan 1, 2019

    Earliest Phase 3 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT03950843Phase 3Apr 23, 2019Ajou University, Catholic University of Korea, Chonbuk National University, Chong Kun Dang Pharmaceutical, Chonnam National University, Chungnam National University, Dong-A University, Gachon University, Hanyang University, Inha University, Inje University, Keimyung University, Kyung Hee University, Sejong General Hospital, Seoul National University, Sungkyunkwan University, University of Ulsan, Wonkwang University, Yonsei University
Showing 1 of 1 trials
Page 1 / 1

Organizations

Research & Development (19)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Ajou UniversityAcademic/Hospital1012019
Catholic University of KoreaAcademic/Hospital1012019
Chonbuk National UniversityAcademic/Hospital1012019
Chong Kun Dang PharmaceuticalFor profit1112019
Chonnam National UniversityAcademic/Hospital1012019
Chungnam National UniversityAcademic/Hospital1012019
Dong-A UniversityAcademic/Hospital1012019
Gachon UniversityAcademic/Hospital1012019
Hanyang UniversityAcademic/Hospital1012019
Inha UniversityAcademic/Hospital1012019
Inje UniversityAcademic/Hospital1012019
Keimyung UniversityAcademic/Hospital1012019
Kyung Hee UniversityAcademic/Hospital1012019
Sejong General HospitalAcademic/Hospital1012019
Seoul National UniversityAcademic/Hospital1012019
Sungkyunkwan UniversityAcademic/Hospital1012019
University of UlsanAcademic/Hospital1012019
Wonkwang UniversityAcademic/Hospital1012019
Yonsei UniversityAcademic/Hospital1012019
19 organizations
Page 1 / 1